Parker-Hannifin (PH): Assessing Valuation as Earnings Anticipation and Analyst Optimism Build

Simply Wall St

Parker-Hannifin (PH) is in the spotlight ahead of its upcoming first-quarter earnings release, which many expect to reveal a profit increase. The company also continues to impress with its long-running record of dividend growth.

See our latest analysis for Parker-Hannifin.

Parker-Hannifin’s share price has cooled in recent weeks, even as anticipation for earnings grows and its stellar 69-year dividend streak grabs headlines. Despite a modest 3.7% drop over the past month, the stock’s strong year-to-date share price return of 15.35% and outstanding 190% three-year total shareholder return highlight its enduring appeal and suggest momentum is still very much alive for long-term investors.

If you’re inspired by Parker-Hannifin’s track record, this could be the perfect moment to see what’s next. Broaden your search and discover fast growing stocks with high insider ownership

With Wall Street calling for further gains and analysts lifting their forecasts, the question now is whether Parker-Hannifin’s current share price leaves room for upside or if future growth is already factored in for investors.

Most Popular Narrative: 8.9% Undervalued

With a narrative fair value set at $797, Parker-Hannifin's last close of $726.16 suggests the company's price may be trailing the outlook of the most widely followed narrative. This creates a sense of anticipation, as expectations appear to be outpacing current market pricing.

The company's enhanced exposure to aftermarket and longer-cycle revenue streams (anticipated to be 85% of the portfolio by 2029) creates higher quality, more recurring income and reduced cyclicality. This should underpin long-term earnings growth and provide earnings stability during future cycles.

Read the complete narrative.

What if the drivers behind this bold valuation are hidden in the company’s evolving business mix and future-looking financial assumptions? A unique blend of recurring revenues, margin expectations, and forward profit multiples are all in play. Curious what’s fueling that price target rise, beyond just headlines? Find out how these numbers stack up in the full narrative.

Result: Fair Value of $797 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, prolonged sluggish demand in key industrial segments or integration challenges from recent acquisitions could still put Parker-Hannifin’s upbeat outlook to the test.

Find out about the key risks to this Parker-Hannifin narrative.

Another View: What Do the Multiples Say?

Looking at Parker-Hannifin through the lens of its price-to-earnings ratio, things look a little less clear-cut. The company’s P/E of 26x is higher than the US Machinery industry average of 24.1x, but it sits well below the peer average of 35x. Against the market-implied fair ratio of 27.7x, Parker-Hannifin appears reasonably valued, offering some balance between risk and opportunity. Does this alignment signal stability or simply mask potential downside?

See what the numbers say about this price — find out in our valuation breakdown.

NYSE:PH PE Ratio as at Oct 2025

Build Your Own Parker-Hannifin Narrative

If you have your own perspective on Parker-Hannifin or want to take a hands-on approach, you can shape your own narrative in just a few minutes. Do it your way

A great starting point for your Parker-Hannifin research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.

Looking for More Investment Ideas?

Don’t settle for just one opportunity. Take the next step and explore stocks set to impact tomorrow’s markets using new strategies that combine momentum, innovation, and value.

  • Pinpoint turnaround opportunities by filtering for these 874 undervalued stocks based on cash flows with strong financials and attractive valuations that may have been overlooked by others.
  • Explore advances in healthcare by reviewing these 33 healthcare AI stocks that leverage breakthrough AI technologies to improve patient outcomes and bring innovation to the industry.
  • Explore growth possibilities with these 24 AI penny stocks focused on the core of the artificial intelligence revolution, influencing change across a variety of sectors.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're here to simplify it.

Discover if Parker-Hannifin might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com